Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility? by Stephanie Kourakis, Cara A. Timpani, Judy B. de Haan, Nuri Gueven, Dirk Fischer, Emma Rybalka

Get full text

Adenylosuccinic Acid: An Orphan Drug with Untapped Potential by Emma Rybalka, Stephanie Kourakis, Charles A. Bonsett, Behzad Moghadaszadeh, Alan H. Beggs, Cara A. Timpani

Get full text

Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy by Stephanie Kourakis, Cara A. Timpani, Judy B. de Haan, Nuri Gueven, Dirk Fischer, Emma Rybalka

Get full text

Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better? by Stephanie Kourakis, Cara A. Timpani, Dean G. Campelj, Patricia Hafner, Nuri Gueven, Dirk Fischer, Emma Rybalka

Get full text

Dimethyl fumarate modulates the dystrophic disease program following short-term treatment by Cara A. Timpani, Stephanie Kourakis, Danielle A. Debruin, Dean G. Campelj, Nancy Pompeani, Narges Dargahi, Angelo P. Bautista, Ryan M. Bagaric, Elya J. Ritenis, Lauren Sahakian, Didier Debrincat, Nicole Stupka, Patricia Hafner, Peter G. Arthur, Jessica R. Terrill, Vasso Apostolopoulos, Judy B. de Haan, Nuri Guven, Dirk Fischer, Emma Rybalka

Get full text